These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 28584147

  • 1. Influence of IS256 on Genome Variability and Formation of Small-Colony Variants in Staphylococcus aureus.
    Kleinert F, Kallies R, Hort M, Zweynert A, Szekat C, Nagel M, Bierbaum G.
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584147
    [Abstract] [Full Text] [Related]

  • 2. Increase in IS256 transposition in invasive vancomycin heteroresistant Staphylococcus aureus isolate belonging to ST100 and its derived VISA mutants.
    Di Gregorio S, Fernandez S, Perazzi B, Bello N, Famiglietti A, Mollerach M.
    Infect Genet Evol; 2016 Sep; 43():197-202. PubMed ID: 27154328
    [Abstract] [Full Text] [Related]

  • 3. Decreased vancomycin susceptibility in Staphylococcus aureus caused by IS256 tempering of WalKR expression.
    McEvoy CR, Tsuji B, Gao W, Seemann T, Porter JL, Doig K, Ngo D, Howden BP, Stinear TP.
    Antimicrob Agents Chemother; 2013 Jul; 57(7):3240-9. PubMed ID: 23629723
    [Abstract] [Full Text] [Related]

  • 4. Different Vancomycin-Intermediate Staphylococcus aureus Phenotypes Selected from the Same ST100-hVISA Parental Strain.
    Di Gregorio S, Fernandez S, Cuirolo A, Verlaine O, Amoroso A, Mengin-Lecreulx D, Famiglietti A, Joris B, Mollerach M.
    Microb Drug Resist; 2017 Jan; 23(1):44-50. PubMed ID: 27991847
    [Abstract] [Full Text] [Related]

  • 5. Emergence of a small colony variant of vancomycin-intermediate Staphylococcus aureus in a patient with septic arthritis during long-term treatment with daptomycin.
    Lin YT, Tsai JC, Yamamoto T, Chen HJ, Hung WC, Hsueh PR, Teng LJ.
    J Antimicrob Chemother; 2016 Jul; 71(7):1807-14. PubMed ID: 26968883
    [Abstract] [Full Text] [Related]

  • 6. A full genomic characterization of the development of a stable Small Colony Variant cell-type by a clinical Staphylococcus aureus strain.
    Bui LMG, Kidd SP.
    Infect Genet Evol; 2015 Dec; 36():345-355. PubMed ID: 26458527
    [Abstract] [Full Text] [Related]

  • 7. Influence of ciprofloxacin and vancomycin on mutation rate and transposition of IS256 in Staphylococcus aureus.
    Nagel M, Reuter T, Jansen A, Szekat C, Bierbaum G.
    Int J Med Microbiol; 2011 Mar; 301(3):229-36. PubMed ID: 21115395
    [Abstract] [Full Text] [Related]

  • 8. Comprehensive identification of mutations responsible for heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA)-to-VISA conversion in laboratory-generated VISA strains derived from hVISA clinical strain Mu3.
    Matsuo M, Cui L, Kim J, Hiramatsu K.
    Antimicrob Agents Chemother; 2013 Dec; 57(12):5843-53. PubMed ID: 24018261
    [Abstract] [Full Text] [Related]

  • 9. Mutated response regulator graR is responsible for phenotypic conversion of Staphylococcus aureus from heterogeneous vancomycin-intermediate resistance to vancomycin-intermediate resistance.
    Neoh HM, Cui L, Yuzawa H, Takeuchi F, Matsuo M, Hiramatsu K.
    Antimicrob Agents Chemother; 2008 Jan; 52(1):45-53. PubMed ID: 17954695
    [Abstract] [Full Text] [Related]

  • 10. Insertion sequence IS256 in canine pyoderma isolates of Staphylococcus pseudintermedius associated with antibiotic resistance.
    Casagrande Proietti P, Bietta A, Coletti M, Marenzoni ML, Scorza AV, Passamonti F.
    Vet Microbiol; 2012 Jun 15; 157(3-4):376-82. PubMed ID: 22261238
    [Abstract] [Full Text] [Related]

  • 11. The evolution of vancomycin intermediate Staphylococcus aureus (VISA) and heterogenous-VISA.
    Howden BP, Peleg AY, Stinear TP.
    Infect Genet Evol; 2014 Jan 15; 21():575-82. PubMed ID: 23567819
    [Abstract] [Full Text] [Related]

  • 12. Reduced susceptibility to vancomycin in isogenic Staphylococcus aureus strains of sequence type 59: tracking evolution and identifying mutations by whole-genome sequencing.
    Chen CJ, Lin MH, Shu JC, Lu JJ.
    J Antimicrob Chemother; 2014 Feb 15; 69(2):349-54. PubMed ID: 24092658
    [Abstract] [Full Text] [Related]

  • 13. VraR Binding to the Promoter Region of agr Inhibits Its Function in Vancomycin-Intermediate Staphylococcus aureus (VISA) and Heterogeneous VISA.
    Dai Y, Chang W, Zhao C, Peng J, Xu L, Lu H, Zhou S, Ma X.
    Antimicrob Agents Chemother; 2017 May 15; 61(5):. PubMed ID: 28289032
    [Abstract] [Full Text] [Related]

  • 14. Mechanisms of vancomycin resistance in Staphylococcus aureus.
    Gardete S, Tomasz A.
    J Clin Invest; 2014 Jul 15; 124(7):2836-40. PubMed ID: 24983424
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Development of an Amplicon Nanopore Sequencing Strategy for Detection of Mutations Conferring Intermediate Resistance to Vancomycin in Staphylococcus aureus Strains.
    Moller AG, Petit RA, Davis MH, Read TD.
    Microbiol Spectr; 2023 Feb 14; 11(1):e0272822. PubMed ID: 36688645
    [Abstract] [Full Text] [Related]

  • 18. sigmaB regulates IS256-mediated Staphylococcus aureus biofilm phenotypic variation.
    Valle J, Vergara-Irigaray M, Merino N, Penadés JR, Lasa I.
    J Bacteriol; 2007 Apr 14; 189(7):2886-96. PubMed ID: 17277051
    [Abstract] [Full Text] [Related]

  • 19. "Slow VISA," a novel phenotype of vancomycin resistance, found in vitro in heterogeneous vancomycin-intermediate Staphylococcus aureus strain Mu3.
    Saito M, Katayama Y, Hishinuma T, Iwamoto A, Aiba Y, Kuwahara-Arai K, Cui L, Matsuo M, Aritaka N, Hiramatsu K.
    Antimicrob Agents Chemother; 2014 Sep 14; 58(9):5024-35. PubMed ID: 24841271
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.